SCHEMBL19009231

SCHEMBL19009231

Cc1cccc(-c2cc(-c3ccccn3)cc(-c3ccccn3)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 6/20 0.57
TGFBR1 P36897 1/20 0.50
DCTPP1 Q9H773 1/20 0.50
KDM4E B2RXH2 4/20 0.47
NPC1 O15118 3/20 0.47
CYP2A6 P11509 1/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
HIF1A Q16665 2/20 0.45
LMNA P02545 2/20 0.45
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45
DOHH Q9BU89 1/20 0.45
P4HTM Q9NXG6 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14979453 0.95 GRM5 (0.59) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL18960592 0.92 GRM5 (0.51) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL29638128 0.91 GRM5 (0.62) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL215712 0.91 GRM5 (0.62) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL18960602 0.89 CYP2A6 (0.61) GRM5TGFBR1NPC1CYP2A6BCHE
SCHEMBL13799169 0.89 GRM5 (0.50) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL31492170 0.89 GRM5 (0.60) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL29427960 0.89 GRM5 (0.60) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL16783703 0.89 GRM5 (0.60) GRM5TGFBR1DCTPP1KDM4ENPC1
SCHEMBL12070461 0.89 KDM4E (0.53) GRM5KDM4ENPC1CYP2A6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174705-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174705-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, C9, CRY2 GRM5 3745/4885TGFBR1 1067/4885DCTPP1 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.